Literature DB >> 23966166

ZNF365 promotes stalled replication forks recovery to maintain genome stability.

Yuqing Zhang1, Eunmi Park, Christopher S Kim, Ji-hye Paik.   

Abstract

The ZNF365 locus is associated with breast cancer risk in carriers of mutated BRCA1 and BRCA2, which are important molecules required for DNA damage response. Previously, we demonstrated that ZNF365 is necessary for timely resolution of replication intermediates of genomic fragile sites and, thus, for suppression of genomic instability; however, the mechanism underlying the function of ZNF365 on damaged DNA and stalled replication forks remains unknown. Here, we demonstrate that ZNF365 is induced by DNA double-strand break (DSB) signals, is involved in the homologous recombination (HR) repair pathway, and maintains genome integrity during DNA replication. On the mechanistic level, ZNF365 interacts with poly(ADP-ribose) polymerase (PARP) 1 to tether MRE11 to the DNA end resection site. Loss of ZNF365 results in delayed mitotic progression and exit due to increased replication stress, ultimately leading to cytokinesis failure, re-duplication of centrosomes, and increased aneuploidy. Collectively, these results suggest an HR repair-dependent function of ZNF365 in preventing genomic instability.

Entities:  

Keywords:  PARP1; ZNF365; cell cycle; genomic instability; replication stress

Mesh:

Substances:

Year:  2013        PMID: 23966166      PMCID: PMC3899195          DOI: 10.4161/cc.25882

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  46 in total

Review 1.  The influence of heterochromatin on DNA double strand break repair: Getting the strong, silent type to relax.

Authors:  Aaron A Goodarzi; Penny Jeggo; Markus Lobrich
Journal:  DNA Repair (Amst)       Date:  2010-10-30

Review 2.  Poly(ADP-ribose) polymerase (PARP-1) in homologous recombination and as a target for cancer therapy.

Authors:  Thomas Helleday; Helen E Bryant; Niklas Schultz
Journal:  Cell Cycle       Date:  2005-09-12       Impact factor: 4.534

3.  ATR homolog Mec1 promotes fork progression, thus averting breaks in replication slow zones.

Authors:  Rita S Cha; Nancy Kleckner
Journal:  Science       Date:  2002-07-26       Impact factor: 47.728

4.  PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites.

Authors:  Jean-François Haince; Darin McDonald; Amélie Rodrigue; Ugo Déry; Jean-Yves Masson; Michael J Hendzel; Guy G Poirier
Journal:  J Biol Chem       Date:  2007-11-19       Impact factor: 5.157

5.  Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins.

Authors:  Ivan Ahel; Dragana Ahel; Takahiro Matsusaka; Allison J Clark; Jonathon Pines; Simon J Boulton; Stephen C West
Journal:  Nature       Date:  2008-01-03       Impact factor: 49.962

6.  p53-independent abrogation of a postmitotic checkpoint contributes to human papillomavirus E6-induced polyploidy.

Authors:  Yingwang Liu; Susan A Heilman; Diego Illanes; Greenfield Sluder; Jason J Chen
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

Review 7.  Chromosomal mutagen sensitivity associated with mutations in BRCA genes.

Authors:  G Speit; K Trenz
Journal:  Cytogenet Genome Res       Date:  2004       Impact factor: 1.636

8.  Replicon clusters are stable units of chromosome structure: evidence that nuclear organization contributes to the efficient activation and propagation of S phase in human cells.

Authors:  D A Jackson; A Pombo
Journal:  J Cell Biol       Date:  1998-03-23       Impact factor: 10.539

9.  DNA end resection, homologous recombination and DNA damage checkpoint activation require CDK1.

Authors:  Grzegorz Ira; Achille Pellicioli; Alitukiriza Balijja; Xuan Wang; Simona Fiorani; Walter Carotenuto; Giordano Liberi; Debra Bressan; Lihong Wan; Nancy M Hollingsworth; James E Haber; Marco Foiani
Journal:  Nature       Date:  2004-10-21       Impact factor: 49.962

10.  Pathway choice in DNA double strand break repair: observations of a balancing act.

Authors:  Inger Brandsma; Dik C Gent
Journal:  Genome Integr       Date:  2012-11-27
View more
  11 in total

1.  A genome-wide association study of autism using the Simons Simplex Collection: Does reducing phenotypic heterogeneity in autism increase genetic homogeneity?

Authors:  Pauline Chaste; Lambertus Klei; Stephan J Sanders; Vanessa Hus; Michael T Murtha; Jennifer K Lowe; A Jeremy Willsey; Daniel Moreno-De-Luca; Timothy W Yu; Eric Fombonne; Daniel Geschwind; Dorothy E Grice; David H Ledbetter; Shrikant M Mane; Donna M Martin; Eric M Morrow; Christopher A Walsh; James S Sutcliffe; Christa Lese Martin; Arthur L Beaudet; Catherine Lord; Matthew W State; Edwin H Cook; Bernie Devlin
Journal:  Biol Psychiatry       Date:  2014-09-30       Impact factor: 13.382

2.  p53 drives a transcriptional program that elicits a non-cell-autonomous response and alters cell state in vivo.

Authors:  Sydney M Moyer; Amanda R Wasylishen; Yuan Qi; Natalie Fowlkes; Xiaoping Su; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-08       Impact factor: 11.205

3.  Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy.

Authors:  Guo Chen; Andrew T Magis; Ke Xu; Dongkyoo Park; David S Yu; Taofeek K Owonikoko; Gabriel L Sica; Sarah W Satola; Suresh S Ramalingam; Walter J Curran; Paul W Doetsch; Xingming Deng
Journal:  J Clin Invest       Date:  2017-12-11       Impact factor: 14.808

4.  Genome-wide association study and admixture mapping reveal new loci associated with total IgE levels in Latinos.

Authors:  Maria Pino-Yanes; Christopher R Gignoux; Joshua M Galanter; Albert M Levin; Catarina D Campbell; Celeste Eng; Scott Huntsman; Katherine K Nishimura; Pierre-Antoine Gourraud; Kiana Mohajeri; Brian J O'Roak; Donglei Hu; Rasika A Mathias; Elizabeth A Nguyen; Lindsey A Roth; Badri Padhukasahasram; Andres Moreno-Estrada; Karla Sandoval; Cheryl A Winkler; Fred Lurmann; Adam Davis; Harold J Farber; Kelley Meade; Pedro C Avila; Denise Serebrisky; Rocio Chapela; Jean G Ford; Michael A Lenoir; Shannon M Thyne; Emerita Brigino-Buenaventura; Luisa N Borrell; William Rodriguez-Cintron; Saunak Sen; Rajesh Kumar; Jose R Rodriguez-Santana; Carlos D Bustamante; Fernando D Martinez; Benjamin A Raby; Scott T Weiss; Dan L Nicolae; Carole Ober; Deborah A Meyers; Eugene R Bleecker; Steven J Mack; Ryan D Hernandez; Evan E Eichler; Kathleen C Barnes; L Keoki Williams; Dara G Torgerson; Esteban G Burchard
Journal:  J Allergy Clin Immunol       Date:  2014-12-06       Impact factor: 10.793

5.  Editor's Highlight: Hydroxyurea Exposure Activates the P53 Signaling Pathway in Murine Organogenesis-Stage Embryos.

Authors:  Nazem El Husseini; Ava E Schlisser; Barbara F Hales
Journal:  Toxicol Sci       Date:  2016-05-13       Impact factor: 4.849

6.  Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression.

Authors:  Hatef Darabi; Karen McCue; Jonathan Beesley; Kyriaki Michailidou; Silje Nord; Siddhartha Kar; Keith Humphreys; Deborah Thompson; Maya Ghoussaini; Manjeet K Bolla; Joe Dennis; Qin Wang; Sander Canisius; Christopher G Scott; Carmel Apicella; John L Hopper; Melissa C Southey; Jennifer Stone; Annegien Broeks; Marjanka K Schmidt; Rodney J Scott; Artitaya Lophatananon; Kenneth Muir; Matthias W Beckmann; Arif B Ekici; Peter A Fasching; Katharina Heusinger; Isabel Dos-Santos-Silva; Julian Peto; Ian Tomlinson; Elinor J Sawyer; Barbara Burwinkel; Frederik Marme; Pascal Guénel; Thérèse Truong; Stig E Bojesen; Henrik Flyger; Javier Benitez; Anna González-Neira; Hoda Anton-Culver; Susan L Neuhausen; Volker Arndt; Hermann Brenner; Christoph Engel; Alfons Meindl; Rita K Schmutzler; Norbert Arnold; Hiltrud Brauch; Ute Hamann; Jenny Chang-Claude; Sofia Khan; Heli Nevanlinna; Hidemi Ito; Keitaro Matsuo; Natalia V Bogdanova; Thilo Dörk; Annika Lindblom; Sara Margolin; Veli-Matti Kosma; Arto Mannermaa; Chiu-Chen Tseng; Anna H Wu; Giuseppe Floris; Diether Lambrechts; Anja Rudolph; Paolo Peterlongo; Paolo Radice; Fergus J Couch; Celine Vachon; Graham G Giles; Catriona McLean; Roger L Milne; Pierre-Antoine Dugué; Christopher A Haiman; Gertraud Maskarinec; Christy Woolcott; Brian E Henderson; Mark S Goldberg; Jacques Simard; Soo H Teo; Shivaani Mariapun; Åslaug Helland; Vilde Haakensen; Wei Zheng; Alicia Beeghly-Fadiel; Rulla Tamimi; Arja Jukkola-Vuorinen; Robert Winqvist; Irene L Andrulis; Julia A Knight; Peter Devilee; Robert A E M Tollenaar; Jonine Figueroa; Montserrat García-Closas; Kamila Czene; Maartje J Hooning; Madeleine Tilanus-Linthorst; Jingmei Li; Yu-Tang Gao; Xiao-Ou Shu; Angela Cox; Simon S Cross; Robert Luben; Kay-Tee Khaw; Ji-Yeob Choi; Daehee Kang; Mikael Hartman; Wei Yen Lim; Maria Kabisch; Diana Torres; Anna Jakubowska; Jan Lubinski; James McKay; Suleeporn Sangrajrang; Amanda E Toland; Drakoulis Yannoukakos; Chen-Yang Shen; Jyh-Cherng Yu; Argyrios Ziogas; Minouk J Schoemaker; Anthony Swerdlow; Anne-Lise Borresen-Dale; Vessela Kristensen; Juliet D French; Stacey L Edwards; Alison M Dunning; Douglas F Easton; Per Hall; Georgia Chenevix-Trench
Journal:  Am J Hum Genet       Date:  2015-06-11       Impact factor: 11.025

7.  Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients.

Authors:  Daniel Lew; Soon Man Yoon; Xiaofei Yan; Lori Robbins; Talin Haritunians; Zhenqiu Liu; Dalin Li; Dermot Pb McGovern
Journal:  World J Gastroenterol       Date:  2017-10-28       Impact factor: 5.742

8.  A Qualitative Transcriptional Signature for Predicting Recurrence Risk for High-Grade Serous Ovarian Cancer Patients Treated With Platinum-Taxane Adjuvant Chemotherapy.

Authors:  Yixin Liu; Zheyang Zhang; Tianhao Li; Xin Li; Sainan Zhang; Ying Li; Wenyuan Zhao; Yunyan Gu; Zheng Guo; Lishuang Qi
Journal:  Front Oncol       Date:  2019-10-18       Impact factor: 6.244

9.  Identifying the Potential Mechanism of Action of SNPs Associated With Breast Cancer Susceptibility With GVITamIN.

Authors:  An-Phi Nguyen; Paola Nicoletti; Damien Arnol; Andrea Califano; María Rodríguez Martínez
Journal:  Front Bioeng Biotechnol       Date:  2020-08-04

10.  Targeting SIRT2 Sensitizes Melanoma Cells to Cisplatin via an EGFR-Dependent Mechanism.

Authors:  Iwona Karwaciak; Anna Sałkowska; Kaja Karaś; Jarosław Dastych; Marcin Ratajewski
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.